Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate- to High-Risk Pulmonary Embolism: A Systematic Review and Meta-Analysis.

EJHaem · 2025 · PMC12141915 · PMID 40485907

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Also, for the post‐ST/CDT‐only studies, there was also a nonsignificant trend towards less risk of major bleeding among DOACs versus warfarin (OR 0.45, 95% CI 0.08–2.56, Q = 0.39, I 2 = 0%) (Figure 4b ). 3.2.2.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.